![KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib]()
KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or ErlotinibPao, William; Wang, Theresa Y.; Riely, Gregory J.; Miller, Vincent A.; Pan, Qiulu; Ladanyi, Marc; Zakowski, Maureen F.; Heelan, Robert T.; Kris, Mark G.; Varmus, Harold E. · PLoS Medicine · 2005